tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMTX Stock Latest News

Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
Company AnnouncementsImmatics Reveals Promising Results from IMA203CD8 Phase 1a Trial
8d ago
6K
IMTX
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
PremiumThe Fly
Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress
8d ago
IMTX
Immatics Completes $116.5 Million Share Offering to Boost R&D
PremiumCompany Announcements
Immatics Completes $116.5 Million Share Offering to Boost R&D
11d ago
6K
IMTX
Immatics announces offering of 12.5M ordinary shares
PremiumThe Fly
Immatics announces offering of 12.5M ordinary shares
14d ago
IMTX
Immatics N.V. Reports Q3 2025 Financial Results and Progress
PremiumCompany Announcements
Immatics N.V. Reports Q3 2025 Financial Results and Progress
24d ago
IMTX
Immatics price target raised to $23 from $19 at Mizuho
PremiumThe FlyImmatics price target raised to $23 from $19 at Mizuho
1M ago
IMTX
Immatics price target raised to $19 from $16 at Guggenheim
Premium
The Fly
Immatics price target raised to $19 from $16 at Guggenheim
1M ago
IMTX
Morning Movers: E.W. Scripps surges after report of Sinclair takeover interest
Premium
The Fly
Morning Movers: E.W. Scripps surges after report of Sinclair takeover interest
1M ago
SEE
SSP
Immatics Reports Q3 2025 Financial Results and Business Update
PremiumCompany Announcements
Immatics Reports Q3 2025 Financial Results and Business Update
1M ago
6K
IMTX
Immatics reports Q3 EPS (EUR 0.42) vs (EUR 0.08) vs last year
PremiumThe Fly
Immatics reports Q3 EPS (EUR 0.42) vs (EUR 0.08) vs last year
1M ago
IMTX
IMTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IMTX Earnings this Week: How Will it Perform?
1M ago
IMTX
Promising Efficacy and Safety of Immatics’ IMA402 and IMA401 Drive Buy Rating
PremiumRatings
Promising Efficacy and Safety of Immatics’ IMA402 and IMA401 Drive Buy Rating
1M ago
IMTX
Immatics Reveals Promising Phase 1a Results for TCR Bispecifics
PremiumCompany AnnouncementsImmatics Reveals Promising Phase 1a Results for TCR Bispecifics
1M ago
6K
IMTX
Immatics announces updated Phase 1a dose escalation data for IMA402, IMA401
Premium
The Fly
Immatics announces updated Phase 1a dose escalation data for IMA402, IMA401
1M ago
IMTX
Immatics price target raised to $19 from $16 at Mizuho
Premium
The Fly
Immatics price target raised to $19 from $16 at Mizuho
2M ago
IMTX
Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition
PremiumCompany Announcements
Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition
2M ago
6K
IMTX
Immatics appoints Krause as Chief People Officer
PremiumThe Fly
Immatics appoints Krause as Chief People Officer
2M ago
IMTX
Immatics’ Promising Efficacy and Strategic Positioning Support Buy Rating
PremiumRatings
Immatics’ Promising Efficacy and Strategic Positioning Support Buy Rating
2M ago
IMTX
Immatics Reports Promising Anzu-cel Results in Uveal Melanoma
PremiumCompany Announcements
Immatics Reports Promising Anzu-cel Results in Uveal Melanoma
2M ago
6K
IMTX
Immatics highlights anti-tumor activity of anzu-cel PRAME cell therapy
PremiumThe FlyImmatics highlights anti-tumor activity of anzu-cel PRAME cell therapy
2M ago
IMTX
Immatics Appoints New CFO to Drive PRAME Therapy Commercialization
Premium
Company Announcements
Immatics Appoints New CFO to Drive PRAME Therapy Commercialization
3M ago
6K
IMTX
Immatics appoints Venkat Ramanan as Chief Financial Officer
Premium
The Fly
Immatics appoints Venkat Ramanan as Chief Financial Officer
3M ago
NVS
IMTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >